Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Simplifying changes requires clear steps and reminders. Learn practical ways to make mid-month edits that stick and save you time.
23,956 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Cardano faces a pivotal test in 2026 as ADA trades near multi-year lows. Analysts say a $1 reclaim is possible but un...
Turnaround stories can spark excitement, but income-focused investors should seek a true dividend top dog. This artic...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
Even as Ethereum faces a brutal price decline, new wallet data shows ethereum more holders than Bitcoin. Analysts say...
Looking to build a global core sleeve for your portfolio? This guide compares Vanguard Total World Stock and VWO, exp...
Regulators take center stage in crypto news as July regulation moves forward. Bitcoin and Ethereum hold steady amid p...
Trade Desk stock jumped on reports of a potential partnership with OpenAI, signaling fresh AI-driven upside for ad-te...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Regulators have cleared XRP as a digital commodity and spot ETFs are attracting flows, but the price has yet to rebou...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
Bitcoin could test lower levels as bearish theses grow louder. This report outlines ticking risk factors, potential p...